On a consolidated basis for 2025, revenue was 5.2 hundred million won, operating profit was 1 hundred million won and net income was 1 hundred million won. In 2024, consolidated revenue was 3.1 hundred million won, with an operating loss of 2 hundred million won and a net loss of 1 hundred million won.
On a standalone basis, 2025 revenue was 4.9 hundred million won, operating profit 4 hundred million won and net income 4 hundred million won, with standalone revenue up 73.8% year on year.
The gap between consolidated and standalone revenue reflects the results of Hannah Health One, the overseas sales subsidiary included in consolidation. A securities information service attributes the improvement to rising consumer preference for safety and for unbleached organic cotton products.
On July 9, 2026, the company resolved to buy back common shares worth 1 hundred million won, with the purchase period set from July 13 to October 12.
The result report filed on October 16, 2026 showed 37,403 shares acquired for 23,087,636 won, and the shortfall against the declared amount was attributed to price movements. Recorded purchase prices were 398 won on July 3, 608 won on July 16 and 673 won on August 31.
As of October 12, 2026, treasury shares held totaled 584,174, or 5.26%. On October 28, 2026, the Korea Exchange announced a notice of possible unfaithful-disclosure designation for a disclosure reversal, and the share price closed that day at 600 won, down 12.92%. The decision deadline for the designation is November 18, 2026.